文献速递肝胆胰外科围术期管理与 ERAS

慢性胰腺炎全胰切除联合自体胰岛移植的患者选择

Patient Selection for Total Pancreatectomy with Islet Autotransplantation in the Surgical Management of Chronic Pancreatitis.
PubMed 文献 · J Am Coll Surg · 2017-12-28

结果显示TPIAT可持久改善胰岛功能、疼痛和生活质量,遗传性胰腺炎、病程短和不吸烟的患者结局更优。

要点

  • TPIAT术后5年胰岛素不依赖率为23%,疼痛和生活质量改善持续至5年。
  • 遗传性胰腺炎、病程短和不吸烟的患者更可能停用胰岛素和麻醉药。
  • 术前每年急诊和住院中位数分别为6.6和4.3次,术后1、2、5年均为0。

核心结论

  • TPIAT是持久有效的手术,胰岛功能、疼痛缓解和生活质量改善可持续至术后5年。
  • 遗传性胰腺炎、病程短和不吸烟的患者结局更优。

研究设计与样本

  • 回顾性分析前瞻性维护的TPIAT患者数据库。

主要发现

  • 平均移植3253胰岛当量/kg,术后1、2、5年胰岛素不依赖率分别为29%、28%、23%。
  • 术前每年急诊和住院中位数分别为6.6和4.3次,术后1、2、5年均为0。
  • 口服吗啡当量中位数术前为214 mg/kg,术后1、2、5年分别为60、64、69 mg/kg。
  • 生活质量评分术前、术后1、2、5年:躯体分别为29、36、34、33(p < 0.01),心理分别为39、44、42、42(p < 0.02)。

临床怎么用

  • 选择TPIAT患者时应考虑病因(遗传性胰腺炎结局更优)、病程长短和吸烟状态。
  • TPIAT可显著减少慢性胰腺炎患者的急诊和住院次数,并持续缓解疼痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Best practice to select patients with chronic pancreatitis for surgical management with total pancreatectomy with islet autotransplantation (TPIAT) is in evolution as new discoveries are made in the pathogenesis of chronic pancreatitis. STUDY DESIGN: A prospectively maintained database of patients undergoing TPIAT was reviewed. Islet function was inferred from daily insulin requirement. Pain relief was evaluated by healthcare use and narcotic use. Quality of life (QOL) was measured with the RAND 12-Item Short Form Survey. RESULTS: One hundred and ninety-five patients (141 women, aged 40.3 years, BMI 26.5 kg/m2) underwent TPIAT. Mean duration of disease before operation was 8.1 years. Fifty-six (29%) patients had pancreatic operations before TPIAT, 37 (19%) patients were diabetic preoperatively, and 52 (27%) patients were smokers. A mean of 3,253 islet equivalents transplanted/kg were harvested. Insulin independence was achieved in 29%, 28%, and 23% of patients at 1, 2, and 5 years postoperative. Nonsmokers with a shorter duration of chronic pancreatitis and no earlier pancreas operation were more likely to be insulin free. Median number of preoperative emergency department visits and hospitalizations were 6.6 and 4.3 annually, respectively, compared with 0 at 1, 2, and 5 years postoperative. Median oral morphine equivalents were 214 mg/kg preoperation and 60, 64, 69, at 1, 2, 5 years postoperative. Preoperative, 1, 2, 5 years postoperative QOL scores were 29, 36, 34, and 33 (physical; p < 0.01) and 39, 44, 42, and 42 (mental health; p < 0.02). Genetic pancreatitis patients were more often narcotic free and had better QOL than patients with pancreatitis of other causes. At 5 years, overall survival was 92.3%. CONCLUSIONS: Total pancreatectomy with islet autotransplantation is a durable operation, with islet function, pain relief, and QOL improvements persisting to 5 years postoperative. Patients with genetic pancreatitis, short duration of disease, and nonsmokers have superior outcomes.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Morgan KA, Lancaster WP, Owczarski SM, et al. Patient Selection for Total Pancreatectomy with Islet Autotransplantation in the Surgical Management of Chronic Pancreatitis. J Am Coll Surg. 2017. PMID: 29289751. doi:10.1016/j.jamcollsurg.2017.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。